Dr. Carabin took over the direction of GREZOSP in the fall of 2020.
The Groupe de recherche en épidémiologie des zoonoses et santé publique (GREZOSP) is a group of researchers and organizations whose mission is to promote research on population-level public and animal health issues in order to guide collective actions and public policy.
Dr. Carabin is co-director of the G1HN network.
​
Global 1 Health Network (G1HN) is an interdisciplinary action research network that aims to strengthen Canadian leadership in improving the global governance of infectious diseases (ID) and antimicrobial resistance (AMR).
​
The network brings together researchers and knowledge users from the social sciences as well as human, animal and environmental health sciences to develop a transdisciplinary One Health approach to the governance of IM and AMR at the global, national and local levels.
Dr. Carabin is responsible for CReSP's One World Health Axis.
Le Centre de recherche en santé publique (CReSP), funded by the Fonds de recherche du Québec - Santé (FRQS), is the result of a partnership between the CIUSSS Centre-Sud-de-l'Île-de-Montréal (CCSMTL) and the Université de Montréal. The CReSP is the first and only major research infrastructure in Quebec entirely dedicated to public health and operating within the framework of privileged structural links with an institution responsible for the health of a population, the CCSMTL.
​
The One World Health Axis brings together several researchers working to better assess the determinants associated with the health status of populations and to develop public health interventions using an approach that respects both the concept of one health and the importance of the social, political and cultural context, while developing methods adapted to these complex systems.
Dr. Carabin is a member of The Lancet One Health Commission.
​
The goal of the Lancet's One Health Commission is to propose a rethought vision of how contemporary global health challenges are intertwined with the complex interconnectedness between humans, animals and their shared environment and to provide an approach to harnessing this knowledge to achieve sustainable health for all. The Commission's work will help explain the importance of the One Health approach to policy by drawing on the expertise and transdisciplinary perspectives of the public and private sectors. The focus will be on infectious diseases, antimicrobial resistance and non-communicable diseases, the latter having often been overlooked in the One Health discourse.
Dre Carabin is co-director of the One Health Modelling Network for Emerging Infections
​
The One Health Modelling Network for Emerging Infections (OMNI-RÉUNIS) is a newly established network born out of the COVID-19 pandemic. Our mission is to build a modelling network that will enhance Canada’s early detection, warning, and response to emerging infectious diseases by systematically incorporating a multi-species, multi-system One Health approach into our thinking, modelling research and training capacity while also recognizing the unique impact emerging infectious diseases has on Indigenous peoples and their communities.
Dr. Carabin is a member of the Scientific Advisory Committee on Global Health
​
In June 2020, the Canadian Institutes of Health Research (CIHR), Global Affairs Canada (GAC), the International Development Research Centre (IDRC) and the Office of International Affairs for the Health Portfolio (OIA), on behalf of Health Canada and the Public Health Agency of Canada, established a shared Scientific Advisory Committee on Global Health (SAC-GH).
​
This committee provides joint access to a structured and regular opportunity for global health decision makers from the federal government to discuss current and emerging issues with one another and with external scientific experts. The mandate of the SAC-GH is to provide independent and objective scientific advice and guidance on global health issues requested by the departments.
Advice from SAC-GH members is meant to be one of many sources of information regarding investments, programs, and policy decision making within the Government of Canada across a range of global health issues.